Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOD1 | Q9Y239 | 5/20 | 0.48 |
| ▸ | FAAH | O00519 | 1/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | LTA4H | P09960 | 2/20 | 0.35 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.35 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29783052 | 1.00 | NOD1 (0.48) | NOD1FAAHL3MBTL1GAAKMT2A | |
| SCHEMBL16976936 | 1.00 | NOD1 (0.48) | NOD1FAAHL3MBTL1GAAKMT2A | |
| Hydrochloric Acid SCHEMBL29783043 | 0.98 | NOD1 (0.47) | NOD1FAAHL3MBTL1GAAKMT2A | |
| Hydrochloric Acid SCHEMBL29783202 | 0.98 | NOD1 (0.47) | NOD1FAAHL3MBTL1GAAKMT2A | |
| SCHEMBL8653509 | 0.87 | FAAH (0.41) | NOD1FAAHALDH1A1LTA4HTSHR | |
| SCHEMBL14281128 | 0.87 | LTA4H (0.45) | NOD1FAAHALDH1A1LTA4H | |
| SCHEMBL623497 | 0.87 | LTA4H (0.45) | NOD1FAAHALDH1A1LTA4H | |
| SCHEMBL23849246 | 0.84 | NOD1 (0.46) | NOD1L3MBTL1GAAKMT2APOLB | |
| SCHEMBL5325285 | 0.83 | NOD1 (0.39) | NOD1FAAHALDH1A1LTA4HTSHR | |
| SCHEMBL29828568 | 0.82 | NOD1 (0.39) | NOD1FAAHALDH1A1LTA4HTSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118416012-A | Lenvatinib mesylate capsule and preparation method thereof | 山东第一医科大学附属肿瘤医院(山东省肿瘤防治研究院、山东省肿瘤医院) | 2024-08-02 | — | — | CN | claimed |
| CN-114766684-A | Protein composition, preparation method and application | 上海艾苛密进出口有限公司 | 2022-07-22 | — | — | CN | claimed |
| CN-114671955-A | Cell activation energy protein and preparation method thereof | 上海艾苛密进出口有限公司 | 2022-06-28 | — | — | CN | claimed |
| CN-103845324-A | Application of theanine fluorine aromatic amide in preparation of products for preventing and treating such diseases as cancer | UNIV YANTAI | 2014-06-11 | — | — | CN | claimed |
| CN-103845325-A | Application of theanine nitrate aromatic amide in preparation of products for preventing and treating such diseases as cancer | UNIV YANTAI | 2014-06-11 | — | — | CN | claimed |
| CN-103690531-A | Application of ethyl coumarin-3-carboxylyl L-theanine and the like in preparation of product used for preventing and treating disease such as cancers | UNIV YANTAI | 2014-04-02 | — | — | CN | claimed |
| CN-103690528-A | Application of ethyl 6-bromocoumarin-3-carboxylyl L-theanine and the like in preparation of product used for preventing and treating disease such as cancers | UNIV YANTAI | 2014-04-02 | — | — | CN | claimed |
| CN-103110621-A | Applications of tea double-chlorine carboxamide and tea double-bromine carboxamide or like in preparation of products for prevention and treatment of diseases such as cancer | UNIV YANTAI | 2013-05-22 | — | — | CN | claimed |
| CN-118416012-A | Lenvatinib mesylate capsule and preparation method thereof | 山东第一医科大学附属肿瘤医院(山东省肿瘤防治研究院、山东省肿瘤医院) | 2024-08-02 | — | — | CN | disclosed |
| CN-118416012-A | Lenvatinib mesylate capsule and preparation method thereof | 山东第一医科大学附属肿瘤医院(山东省肿瘤防治研究院、山东省肿瘤医院) | 2024-08-02 | — | — | CN | disclosed |
| CN-114766684-A | Protein composition, preparation method and application | 上海艾苛密进出口有限公司 | 2022-07-22 | — | — | CN | disclosed |
| CN-114766684-A | Protein composition, preparation method and application | 上海艾苛密进出口有限公司 | 2022-07-22 | — | — | CN | disclosed |
| CN-114671955-A | Cell activation energy protein and preparation method thereof | 上海艾苛密进出口有限公司 | 2022-06-28 | — | — | CN | disclosed |
| CN-114671955-A | Cell activation energy protein and preparation method thereof | 上海艾苛密进出口有限公司 | 2022-06-28 | — | — | CN | disclosed |
| CN-103845324-A | Application of theanine fluorine aromatic amide in preparation of products for preventing and treating such diseases as cancer | UNIV YANTAI | 2014-06-11 | — | — | CN | disclosed |
| CN-103845325-A | Application of theanine nitrate aromatic amide in preparation of products for preventing and treating such diseases as cancer | UNIV YANTAI | 2014-06-11 | — | — | CN | disclosed |
| CN-103690528-A | Application of ethyl 6-bromocoumarin-3-carboxylyl L-theanine and the like in preparation of product used for preventing and treating disease such as cancers | UNIV YANTAI | 2014-04-02 | — | — | CN | disclosed |
| CN-103690531-A | Application of ethyl coumarin-3-carboxylyl L-theanine and the like in preparation of product used for preventing and treating disease such as cancers | UNIV YANTAI | 2014-04-02 | — | — | CN | disclosed |
| CN-103110621-A | Applications of tea double-chlorine carboxamide and tea double-bromine carboxamide or like in preparation of products for prevention and treatment of diseases such as cancer | UNIV YANTAI | 2013-05-22 | — | — | CN | disclosed |
| US-20090281186-A1 | Composition and Method for Reducing Stress | NORTHERN INNOVATIONS AND FORMULATIONS CORP (CA) | 2009-11-12 | — | — | US | disclosed |